Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01295125 · ClinicalTrials.gov registry record · NA

Comparative Study of Biologic Mesh Versus Repair With Component Separation.

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT01295125 is a NA study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01295125, a NA study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to compare open abdominal incisional hernia repair using XenMATRIX biologic mesh versus repair with their own tissue. This study will provide information in determining if a biological mesh is necessary to provide a sturdy repair for a ventral hernia.

Interventions

  • DEVICE XenMATRIX mesh
  • PROCEDURE Open abdominal ventral hernia repair

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2011-01
Est. Completion 2012-05
Phase NA

What the Registry Record Tells You About NCT01295125

The ClinicalTrials.gov registry entry for NCT01295125 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which XenMATRIX mesh is the first listed.

NCT01295125 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01295125 about?

NCT01295125 is a clinical study titled "Comparative Study of Biologic Mesh Versus Repair With Component Separation.". The purpose of this study is to compare open abdominal incisional hernia repair using XenMATRIX biologic mesh versus repair with their own tissue. This study will provide information in determining if a biological mesh is necessary to provide a sturdy repair for a ventral hernia.

What is the current status of trial NCT01295125?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2011-01. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01295125?

The interventions under investigation include: XenMATRIX mesh (DEVICE), Open abdominal ventral hernia repair (PROCEDURE).

Who is sponsoring clinical trial NCT01295125?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.